These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28045358)

  • 1. [Not Available].
    Simeon L; Wuillemin WA
    Ther Umsch; 2016; 73(10):561-566. PubMed ID: 28045358
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peri-Interventional Management of Direct Oral Anticoagulants - Balancing Benefits and Risks].
    Dülgeroglu J; Schmidt D
    Praxis (Bern 1994); 2018 Apr; 107(9-10):485-493. PubMed ID: 29690851
    [No Abstract]   [Full Text] [Related]  

  • 3. Modern Treatment Modalities and Duration of Treatment for Venous Thromboembolism.
    Robert-Ebadi H; Righini M
    Ther Umsch; 2016; 73(10):618-625. PubMed ID: 28045360
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET.
    Grandone E; Aucella F; Barcellona D; Brunori G; Forneris G; Gresele P; Marietta M; Poli D; Testa S; Tripodi A; Genovesi SC
    Blood Transfus; 2020 Nov; 18(6):478-485. PubMed ID: 33000751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of NOAK administration during invasive or surgical interventions : When and how to pause and when to restart?].
    Buerke M; Hoffmeister HM
    Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):105-110. PubMed ID: 28074293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidotes to non-vitamin K oral anticoagulants: necessary or not?
    Proietti M; Lip GY
    Expert Opin Pharmacother; 2015; 16(11):1573-6. PubMed ID: 26077323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug Interactions.
    Pan EY; Sobieraj DM
    Conn Med; 2016 Feb; 80(2):105-11. PubMed ID: 27024982
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulation and Renal Insufficiency.
    Koulouri A; Calanca L; Mazzolai L
    Ther Umsch; 2016; 73(10):567-572. PubMed ID: 28045357
    [No Abstract]   [Full Text] [Related]  

  • 10. Ninety-day prognosis of patients receiving direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: The real life evidence.
    Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Spolveri S; Panigada G; Landini G
    Thromb Res; 2018 Dec; 172():165-168. PubMed ID: 30419471
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Multimorbid Patient: Use of New Oral Anticoagulants in Patients with Chronic Kidney Disease].
    Mohebbi N
    Praxis (Bern 1994); 2018 Jun; 107(13):683-687. PubMed ID: 29921184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].
    Oberhofer E
    MMW Fortschr Med; 2015 Jan; 157(1):24. PubMed ID: 25743289
    [No Abstract]   [Full Text] [Related]  

  • 13. Security profile of direct anticoagulants. Preferred use in atrial fibrillation.
    Roldán Rabadán I; Alonso de Leciñana M; Barba Martín R; Páramo Fernández JA;
    Clin Investig Arterioscler; 2019; 31(6):263-270. PubMed ID: 31213323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.
    Pollack CV
    Circulation; 2016 Jan; 133(2):e18-9. PubMed ID: 27028439
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function.
    Hernandez I; Smith KJ; Zhang Y
    Thromb Res; 2017 Feb; 150():123-130. PubMed ID: 27771008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.
    Eikelboom J; Merli G
    Am J Med; 2016 Nov; 129(11S):S33-S40. PubMed ID: 27586367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Själander S; Själander A
    Lakartidningen; 2018 Dec; 115():. PubMed ID: 30512136
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effective anticoagulation also in advanced age].
    Zimmermann W
    MMW Fortschr Med; 2015 Feb; 157(3):72. PubMed ID: 25743684
    [No Abstract]   [Full Text] [Related]  

  • 19. [New oral anticoagulants in patients with atrial fibrillation in a urban health center].
    Rodríguez Pérez L; Capilla Lozano F; Gallego Fuentes R; Buitrago F
    Med Clin (Barc); 2016 Mar; 146(6):280-1. PubMed ID: 26343157
    [No Abstract]   [Full Text] [Related]  

  • 20. Facing real-life with direct oral anticoagulants in patients with nonvalvular atrial fibrillation: outcomes from the first observational and prospective study in a Spanish population.
    Cerdá M; Cerezo-Manchado JJ; Johansson E; Martínez F; Fernández M; Varela A; Rodríguez S; Bosch F; Santamaría A
    J Comp Eff Res; 2019 Feb; 8(3):165-178. PubMed ID: 30654626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.